Atlas Trials

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment

Clinical trial NCT01762462 · COMPLETED

Trial details

NCT number
NCT01762462
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2012-12-01
Primary completion
2013-03-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.